Michael J. Forrest

2.8k total citations
37 papers, 2.0k citations indexed

About

Michael J. Forrest is a scholar working on Molecular Biology, Physiology and Animal Science and Zoology. According to data from OpenAlex, Michael J. Forrest has authored 37 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Physiology and 9 papers in Animal Science and Zoology. Recurrent topics in Michael J. Forrest's work include Receptor Mechanisms and Signaling (10 papers), Pharmacological Effects and Assays (9 papers) and Adipose Tissue and Metabolism (9 papers). Michael J. Forrest is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Pharmacological Effects and Assays (9 papers) and Adipose Tissue and Metabolism (9 papers). Michael J. Forrest collaborates with scholars based in United States, Australia and United Kingdom. Michael J. Forrest's co-authors include D. Euan MacIntyre, Jill A. Lindia, Larry Peterson, John S. Mudgett, Catherine Abbadie, Anne Marie Cumiskey, E K Bayne, Julie A. DeMartino, Margaret A. Cascieri and Mari R. Candelore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Endocrinology.

In The Last Decade

Michael J. Forrest

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Forrest United States 21 786 778 367 309 224 37 2.0k
Randy L. Webb United States 29 1.1k 1.4× 583 0.7× 240 0.7× 175 0.6× 137 0.6× 78 3.4k
Michael D. Knierman United States 24 1.5k 1.9× 594 0.8× 449 1.2× 152 0.5× 651 2.9× 43 3.2k
Volker Breu Switzerland 34 1.5k 1.9× 2.3k 3.0× 288 0.8× 121 0.4× 171 0.8× 56 4.9k
S. Nicosia Italy 28 948 1.2× 707 0.9× 546 1.5× 88 0.3× 88 0.4× 89 2.3k
Julien Hanson Belgium 27 1.0k 1.3× 410 0.5× 313 0.9× 146 0.5× 54 0.2× 63 2.3k
Fiorella Marcheselli Italy 19 734 0.9× 583 0.7× 102 0.3× 171 0.6× 523 2.3× 56 2.1k
Giancarlo Folco Italy 34 729 0.9× 1.2k 1.6× 304 0.8× 176 0.6× 47 0.2× 107 2.9k
M G Collis United Kingdom 28 992 1.3× 560 0.7× 502 1.4× 216 0.7× 164 0.7× 61 2.7k
Yoshiki Yui Japan 32 673 0.9× 947 1.2× 490 1.3× 54 0.2× 106 0.5× 91 3.0k
John C. Anthes United States 22 1.3k 1.7× 638 0.8× 282 0.8× 117 0.4× 98 0.4× 62 2.3k

Countries citing papers authored by Michael J. Forrest

Since Specialization
Citations

This map shows the geographic impact of Michael J. Forrest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Forrest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Forrest more than expected).

Fields of papers citing papers by Michael J. Forrest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Forrest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Forrest. The network helps show where Michael J. Forrest may publish in the future.

Co-authorship network of co-authors of Michael J. Forrest

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Forrest. A scholar is included among the top collaborators of Michael J. Forrest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Forrest. Michael J. Forrest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiaoyan, Julie Lao, Alessandro Pocai, et al.. (2015). Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats. Cardiovascular Diabetology. 14(1). 29–29. 21 indexed citations
2.
Cai, Tian‐Quan, L. Alexandra Wickham, Gary R. Sitko, et al.. (2015). Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonist. European Journal of Pharmacology. 758. 107–114. 13 indexed citations
3.
Johns, Douglas G., Joseph Duffy, Timothy S. Fisher, Brian K. Hubbard, & Michael J. Forrest. (2012). On- and Off-Target Pharmacology of Torcetrapib. Drugs. 72(4). 491–507. 39 indexed citations
4.
Zhou, Xiaoyan, Martin F. Crook, Yonghua Zhu, et al.. (2011). Chronic Antagonism of the Mineralocorticoid Receptor Ameliorates Hypertension and End Organ Damage in a Rodent Model of Salt-Sensitive Hypertension. Clinical and Experimental Hypertension. 33(8). 538–547. 10 indexed citations
5.
Carballo‐Jane, Ester, Silvi Luell, Michael W. Wolff, et al.. (2007). Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists. Journal of Pharmacological and Toxicological Methods. 56(3). 308–316. 13 indexed citations
6.
Hale, Jeffrey J., George Doherty, Sander G. Mills, et al.. (2004). Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(13). 3501–3505. 39 indexed citations
7.
Carballo‐Jane, Ester, Shilpa Pandit, Joseph C. Santoro, et al.. (2004). Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation. The Journal of Steroid Biochemistry and Molecular Biology. 88(2). 191–201. 27 indexed citations
8.
Xie, Jenny, Naomi Nomura, Sam L. Koprak, et al.. (2003). Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells. The Journal of Immunology. 170(7). 3662–3670. 100 indexed citations
9.
Edmondson, Scott D., Anthony Mastracchio, Jiafang He, et al.. (2003). Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3983–3987. 28 indexed citations
10.
Forrest, Michael J., et al.. (2000). An Inertial Navigation Data Fusion System employing an Artificial Neural Network as the Data Integrator. 153–158. 8 indexed citations
11.
Biftu, Tesfaye, Dennis Feng, Gui‐Bai Liang, et al.. (2000). Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective β3 adrenergic receptor agonist antiobesity agents. Bioorganic & Medicinal Chemistry Letters. 10(13). 1431–1434. 17 indexed citations
12.
Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations
13.
Forrest, Michael J., Gary J. Hom, Mari R. Candelore, et al.. (2000). L-750355, a human ß3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey. European Journal of Pharmacology. 407(1-2). 175–181. 8 indexed citations
14.
Shih, Thomas L., Mari R. Candelore, Margaret A. Cascieri, et al.. (1999). L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 9(9). 1251–1254. 41 indexed citations
15.
Naylor, Elizabeth M., Emma R. Parmee, Vincent J. Colandrea, et al.. (1999). Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9(5). 755–758. 37 indexed citations
16.
Parmee, Emma R., Elizabeth M. Naylor, Vincent J. Colandrea, et al.. (1999). Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. Bioorganic & Medicinal Chemistry Letters. 9(5). 749–754. 25 indexed citations
17.
Kelly, Linda, Pasquale P. Vicario, G M Thompson, et al.. (1998). Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. Endocrinology. 139(12). 4920–4927. 245 indexed citations
18.
Naylor, Elizabeth M., Vincent J. Colandrea, Mari R. Candelore, et al.. (1998). 3-pyridylethanolamines: Potent and selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 8(21). 3087–3092. 27 indexed citations
19.
DeLano, Frank A., Michael J. Forrest, & Geert W. Schmid‐Schönbein. (1997). Attenuation of Oxygen Free Radical Formation and Tissue Injury During Experimental Inflammation by P‐selectin Blockade. Microcirculation. 4(3). 349–357. 30 indexed citations
20.
Takagi, Toshitaka, Michael J. Forrest, & Peter Brooks. (1987). A pharmacological and histological examination of the microcirculation of the rat subcutaneous air-pouch: microcirculation of the rat air-pouch. Pathology. 19(3). 294–298. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026